Aktiesnakken — April 2020
-
New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis https://www.gene.com/media/press-releases/14848/2020-04-27/new-6-year-data-for-genentechs-ocrevus-o
-
Deutsche Telekom (DTE GY) has informed the German government it is planning to intensify its cooperation with Huawei on 5G network - Handelsblatt
-
Positive resultater fra Gilead
-
vedr coronavirus
-
Gilead reports ‘positive data’ on remdesivir coronavirus drug trial
-
Der er links inde i Covid-19 chatten
-
Sektorrotation ud af healthcare, rammer DK
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind